C. Verlingue

2.2k citations

31 papers · 1.4k indexed · 1 hit paper · h-index 14

Impact in

Pulmonary and Respiratory Medicine top 2%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
Genetics top 5%
- Congenital Ear and Nasal Anomalies
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities

Papers in

Pulmonary and Respiratory Medicine 29
- Cystic Fibrosis Research Advances 28
- Neonatal Respiratory Health Research 17
- Tracheal and airway disorders 5
Genetics 6
- Congenital Ear and Nasal Anomalies 6
- Genomics and Rare Diseases 4
- Genetics and Neurodevelopmental Disorders 2

Co-authors: Bernard Mercier Claude Férec Willy Lissens Miguel Chillón M. Claustres Lluís Bassas S. Silber Teresa Casals
Journals: Human Genetics (5 papers)Human Mutation (3 papers)Clinical Genetics (3 papers)Human Molecular Genetics (2 papers)Journal of Medical Genetics (2 papers)
Partner nations: France Italy Canada

In The Last Decade

C. Verlingue

31 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens 1995 · 680 citations

Peers

Countries citing papers authored by C. Verlingue

Since Specialization

Citations

This map shows the geographic impact of C. Verlingue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Verlingue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Verlingue more than expected).

Fields of papers citing papers by C. Verlingue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Verlingue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Verlingue. The network helps show where C. Verlingue may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Verlingue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Verlingue Line = papers co-authored together C. Verlingue links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis Clinical Genetics ·Virginie Scotet, Marc De Braekeleer, M.‐P. Audrézet, Laurence Lodé, C. Verlingue, I. Quéré, Bernard Mercier, I. Duguépéroux, Halima Kagee, Elío Díez Feijóo, Philippe Parent, Claude Férec	2001	28
2	Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis The Lancet ·Virginie Scotet, Marc De Braekeleer, Michel Roussey, G. Rault, Philippe Parent, M. Dagorne, Hubert Journel, Abraham Ben Yaacov, Halima Kagee, Michel Catheline, Véronique David, André Chaventré, I. Duguépéroux, C. Verlingue, I. Quéré, Bernard Mercier, Marie‐Pierre Audrézet, Claude Férec	2000	85
3	Complete identification of cystic fibrosis transmembrane conductance regulator mutations in the CF population of Saguenay Lac-Saint-Jean (Quebec, Canada) Clinical Genetics ·Marc De Braekeleer, 若林美之, C. Verlingue, Christian Allard, Jean‐Pierre Leblanc, Tim Kämpfer, G Aubin, Claude Férec	1998	13
4	Identification of four novel mutations in the cystic fibrosis transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA, and ΔM1140 Human Mutation ·Christine Clavel, Hironobu Yoshida, José Calpa, C. Verlingue, Philippe Birembaut, Claude Férec	1997	3
5	Linkage disequilibrium between the four most common cystic fibrosis mutations and microsatellite haplotypes in the Celtic population of Brittany Human Genetics ·Marc De Braekeleer, André Chaventré, Giorgio Bertorelle, C. Verlingue, Odile Raguénès, Bernard Mercier, Claude Férec	1996	6
6	Distribution of CFTR Mutations inCystic Fibrosis Patients of TunisianOrigin: Identification of Two NovelMutations European Journal of Human Genetics ·Taïeb Messaoud, C. Verlingue, Érick Denamur, 淳日暮, I. Quéré, Slaheddine Fattoum, Jacques Élion, Claude Férec	1996	29
7	Le gène CFTR: agénésie des déferents et mucoviscidose, deux maladies pour un même gène médecine/sciences ·Claude Férec, C. Verlingue, Bernard Mercier	1996	3
8	Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses Human Genetics ·Claude Férec, C. Verlingue, Philippe Parent, Reis Valdecira Carneiro da Silva, Halima Kagee, G. Rault, M. Dagorne, Abraham Ben Yaacov, Hubert Journel, M. Roussey, B. Le Marec, Michel Catheline, M.‐P. Audrézet, Bernard Mercier	1995	32
9	Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel alleles Human Mutation ·C. Verlingue, Leroy T. Laase, Bernard Mercier, E. K. Ginter, Н.В. Петрова, M.‐P. Audrézet, Claude Férec	1995	7
10	Identification of six novel CFTR mutations in a sample of Italian cystic fibrosis patients Molecular and Cellular Probes ·Claude Férec, Giuseppe Novelli, C. Verlingue, I. Quéré, Bruno Dallapiccola, Marie‐Pierre Audrézet, Bernard Mercier	1995	6
11	Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens New England Journal of Medicine ·Miguel Chillón, Teresa Casals, Bernard Mercier, Lluís Bassas, Willy Lissens, S. Silber, Marie‐Catherine Romey, Kevin A. McDonald, C. Verlingue, M. Claustres, (unknown), (unknown), (unknown) Hit paper breakdown →	1995	680
12	Identification of two novel mutations in the CFTR gene: 3007 del G and 3271 +1 G→A Human Mutation ·Bernard Mercier, SM Weindling, J Feigelson, Chun-Myoung Park, Odile Raguénès, C. Verlingue, I. Quéré, Claude Férec	1994	1
13	Complete detection of mutations in cystic fibrosis patients of Native American origin Human Genetics ·Bernard Mercier, Ryan Debbiny, Xavier Estivill, Núria Morral, Qi Guo, M McClure, Theresa A. Grebe, David Keßler, U Kunze, H Quintelier, Cristina Bombieri, Can Cemgil, C. Verlingue, Yohesuwary G VimalReddy K.	1994	24
14	Prenatal Diagnosis of Cystic Fibrosis in Different European Populations: Application of Denaturing Gradient Gel Electrophoresis Fetal Diagnosis and Therapy ·Claude Férec, C. Verlingue, Marie‐Pierre Audrézet, H. Guillermit, I. Quéré, Odile Raguénès, Bernard Mercier	1993	7
15	Screening for cystic fibrosis in dried blood spots of newborns Molecular and Cellular Probes ·M.‐P. Audrézet, Bruno Costes, N. Ghanem, Pascale Fanen, C. Verlingue, Reis Valdecira Carneiro da Silva, Bernard Mercier, Michel Goossens, Claude Férec	1993	25
16	Identification of 12 novel mutations in the CFTR gene Human Molecular Genetics ·Marie‐Pierre Audrézet, Bernard Mercier, H. Guillermit, I. Quéré, C. Verlingue, G. Rault, Claude Férec	1993	60
17	Asymptomatic carrier of two CFTR mutations: Consequences for prenatal diagnosis? Prenatal Diagnosis ·C. Verlingue, A. David, Marie‐Pierre Audrézet, R. Tahri, Bernard Mercier, Jean‐Paul Moisan, Claude Férec	1993	14
18	Genotype analysis of adult cystic fibrosis patients Human Molecular Genetics ·Claude Férec, C. Verlingue, Mrs. Greeshma Minesh, I. Quéré, Odile Raguénès, J Feigelson, Klopper, Philippe Moullier, Bernard Mercier	1993	22
19	Detection of over 98% cystic fibrosis mutations in a Celtic population Nature Genetics ·Claude Férec, M.‐P. Audrézet, Bernard Mercier, H. Guillermit, Jettie A. Siemerink, I. Quéré, C. Verlingue	1992	139
20	HLA class II genes poIymorphism in DR4 giant cell arteritis patients Tissue Antigens ·Jean‐Denis Bignon, Claude Férec, J Barrier, Y Pennec, C. Verlingue, Rebecca C. Shannon, Virgil S. Lucas, Jakob Müller, Académie Royale	1988	7

About C. Verlingue

C. Verlingue is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Genetics, Immunology and Allergy and Emergency Medical Services, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (28 papers), Neonatal Respiratory Health Research (17 papers), Congenital Ear and Nasal Anomalies (6 papers), Tracheal and airway disorders (5 papers), Genomics and Rare Diseases (4 papers), Genetics and Neurodevelopmental Disorders (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Genetics (211 citations), Reproductive Medicine (109 citations), Pediatrics, Perinatology and Child Health (178 citations) and Genetics (232 citations). C. Verlingue has collaborated with scholars based in France, Italy and Canada. Frequent co-authors include Bernard Mercier, Claude Férec, Willy Lissens, Miguel Chillón, M. Claustres, Lluís Bassas, S. Silber, Teresa Casals, Marie‐Catherine Romey and I. Quéré. Their work appears in journals such as Human Genetics, Human Mutation, Clinical Genetics, Human Molecular Genetics and Journal of Medical Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact